|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.7 TWD | +2.14% |
|
+0.53% | -13.42% |
| May. 15 | Adimmune Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 28 | Adimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Adimmune Corporation reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 43.88 million compared to TWD 169.71 million a year ago. Net loss was TWD 183.97 million compared to TWD 249.01 million a year ago.
Basic loss per share from continuing operations was TWD 0.44 compared to TWD 0.59 a year ago. Diluted loss per share from continuing operations was TWD 0.44 compared to TWD 0.59 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.42% | 364M | |
| +2.87% | 94.22B | |
| -4.08% | 37.76B | |
| -14.01% | 32.5B | |
| +73.38% | 27.75B | |
| -11.57% | 16.13B | |
| -1.78% | 14.19B | |
| -11.67% | 11.42B | |
| +190.36% | 11.06B | |
| -52.61% | 9.09B |
ADIMMUNE CORPORATION 
